Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   CEPS(Rs) -44.2617.0052.4650.1042.28

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is -44.26 based on Mar2024 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar2024-44.26
Mar202317.00
Mar202252.46
Mar202150.10
Mar202042.28

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46
4.71
Mar2021 50.1
18.50
Mar2020 42.28 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,351.3 Cr -4% 27.2% 51.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,712.0 Cr -1.2% 1.3% 5.7% Stock Analytics
DIVIS LABORATORIES ₹176,623.0 Cr -2% 1.3% 45.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,285.0 Cr 1.4% 11.9% 15.7% Stock Analytics
CIPLA ₹119,010.0 Cr -0.6% -2% -1.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,118.0 Cr -1.2% -6.7% -8.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4%

27.2%

51.1%

SENSEX

0.1%

1%

2.6%


You may also like the below Video Courses